文献速递关节外科运动医学

美国肩肘外科医师评分多大变化代表肩关节置换术后有临床重要意义

What Change in American Shoulder and Elbow Surgeons Score Represents a Clinically Important Change After Shoulder Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2016-07-08

该研究基于2007至2013年机构肩关节置换登记数据,回顾性分析490例初次解剖型或反式全肩关节置换患者。采用锚定法计算ASES评分的MCID和SCB,并分析患者相关因素。结果显示总体MCID范围6.3至13.5,SCB范围12.0至36.6;解剖型与反式置换间无差异;术前评分高、反式置换和类风湿关节炎是不达MCID的独立预测因素。

要点

  • ASES评分改善至少9分代表临床重要变化,至少23分代表实质临床获益。
  • 解剖型与反式全肩关节置换的MCID和SCB无显著差异。
  • 术前功能评分高与全肩关节置换后达到临床重要变化的可能性降低相关。

核心结论

  • 接受初次常规全肩关节或反式全肩关节置换的盂肱关节炎或肩袖撕裂关节病患者,ASES评分改善至少9分即体验临床重要变化,改善至少23分即体验实质临床获益。
  • 术前功能评分高与全肩关节置换后达到临床重要变化的可能性降低相关。

研究设计与样本

  • 回顾性查询纵向维持的机构肩关节置换登记数据库,纳入2007至2013年接受初次解剖型或反式全肩关节置换且随访至少2年的患者。
  • 794例患者被识别为符合条件,其中304例无2年随访或数据集不完整,最终研究队列为490例(占794例潜在合格者的62%)。
  • 采用锚定法计算ASES评分的MCID和SCB,使用四个不同锚定测量工作满意度、活动满意度、总体满意度和SF-36活动。
  • 计算整个队列及按置换类型分层的MCID(锚定于有点满意)和SCB(非常满意),并进行多因素logistic回归分析影响MCID和SCB达成的患者相关因素。

主要发现

  • 所有患者合并的MCID范围为6.3至13.5;对于总体满意度锚定,MCID为13.5±4.5(95%CI,4.8-22.3)。
  • 整个队列的SCB范围为12.0至36.6;对于总体满意度锚定,SCB为36.6±3.8(95%CI,29.1-44.1)。
  • 解剖型与反式全肩关节置换在任一锚定的MCID上均无差异(p=0.159-0.992),在任一锚定的SCB上也无差异(p=0.467-0.977)。
  • 合并解剖型和反式全肩关节置换为一组,较高的术前ASES评分(OR,0.96;95%CI,0.94-0.98;p<0.001)、接受反式全肩关节置换(OR,0.36;95%CI,0.16-0.85;p=0.016)和患有类风湿关节炎是术后2年未达ASES评分MCID的独立预测因素。
  • 较高的术前ASES评分(OR,0.91;95%CI,0.89-0.92;p<0.001)、肩袖撕裂关节病诊断(OR,0.14;95%CI,0.07-0.30;p<0.001)、背痛诊断(OR,0.42;95%CI,0.24-0.71;p=0.002)和独居(OR,0.36;95%CI,0.19-0.69;p=0.002)均为肩关节置换后未达SCB的独立预测因素。

关键数值与推荐

  • ASES评分改善至少9分代表临床重要变化。
  • ASES评分改善至少23分代表实质临床获益。
  • 较高术前ASES评分、反式全肩关节置换和类风湿关节炎是不达MCID的独立预测因素。
  • 较高术前ASES评分、肩袖撕裂关节病、背痛和独居是不达SCB的独立预测因素。

临床怎么用

  • 对于接受初次常规全肩关节或反式全肩关节置换的盂肱关节炎或肩袖撕裂关节病患者,ASES评分改善至少9分可视为临床重要变化,至少23分可视为实质临床获益。
  • 术前功能评分较高的患者在全肩关节置换后达到临床重要变化的可能性降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American Shoulder and Elbow Surgeons (ASES) questionnaire was developed to provide a standardized method for evaluating shoulder function. Previous studies have determined the clinical responsiveness of this outcome measure for heterogenous populations or patients with nonoperatively treated rotator cuff disease. Currently, to our knowledge, no studies exist that establish the clinically relevant change in the ASES score after shoulder arthroplasty. QUESTIONS/PURPOSES: We asked: (1) What are the minimal clinically important difference (MCID) and substantial clinical benefit (SCB) for the ASES score after primary and reverse shoulder arthroplasties? (2) Are the MCID and SCB for the ASES score different between primary and reverse shoulder arthroplasties? (3) What patient-related factors are associated with achieving the MCID and SCB after total shoulder arthroplasty and reverse shoulder arthroplasty? METHODS: A longitudinally maintained institutional shoulder arthroplasty registry was retrospectively queried for patients who underwent primary shoulder arthroplasty, including anatomic or reverse total shoulder arthroplasty from 2007 to 2013, with a minimum 2-year followup. Seven hundred ninety-four patients were identified and eligible; 304 of these patients did not have 2 years of followup or complete datasets, resulting in a study cohort of 490 patients (62% of the 794 potentially eligible). The MCID and SCB of the ASES score for these patients was calculated using an anchor-based method, using four different anchors measuring satisfaction with work, activities, overall, and activity from the SF-36. The MCID (anchored to somewhat satisfied) and SCB (very satisfied) of the ASES score were calculated for the entire cohort and stratified by arthroplasty type. Multivariate logistic regression of patient-related factors that influence the MCID and SCB achievement was performed. RESULTS: The MCID for all patients combined ranged from 6.3 to 13.5; for the overall satisfaction anchor, the MCID was 13.5 ± 4.5 (95% CI, 4.8-22.3). The SCB for the overall cohort ranged from 12.0 to 36.6; for the overall satisfaction anchor, the SCB was 36.6 ± 3.8 (95% CI, 29.1-44.1). There were no differences in the MCID of the ASES score between anatomic and reverse shoulder arthroplasty for any of the anchors (p = 0.159-0.992) or the SCB for any of the anchors (p = 0.467-0.977). Combining anatomic and reverse shoulder arthroplasty in one group, higher preoperative ASES score (odds ratio [OR], 0.96; 95% CI, 0.94-0.98; p < 0.001), having a reverse shoulder arthroplasty (OR, 0.36; 95% CI, 0.16-0.85; p = 0.016), and having rheumatoid arthritis were independent predictors of not achieving an MCID for the ASES 2 years after surgery. Higher preoperative ASES score (OR, 0.91; 95% CI, 0.89-0.92; p < 0.001), a diagnosis of rotator cuff tear arthropathy (OR, 0.14; 95% CI, 0.07-0.30; p < 0.001), a diagnosis of back pain (OR, 0.42; 95% CI, 0.24-0.71); p = 0.002), and living alone (OR, 0.36; 95% CI, 0.19-0.69; p = 0.002) were all independent predictors of not achieving SCB after shoulder arthroplasty. CONCLUSIONS: Patients with glenohumeral arthritis or rotator cuff tear arthropathy who undergo primary conventional total or reverse shoulder arthroplasty and have at least a nine-point improvement in their ASES score experience a clinically important change, whereas those who have at least a 23-point improvement in their ASES score experience a substantial clinical benefit. High preoperative function was associated with a decreased likelihood of achieving clinically important change after total shoulder arthroplasty. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Werner BC, Chang B, Nguyen JT, et al. What Change in American Shoulder and Elbow Surgeons Score Represents a Clinically Important Change After Shoulder Arthroplasty? Clin Orthop Relat Res. 2016. PMID: 27392769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。